标题
Colorectal cancer vaccines: Tumor-associated antigens vs neoantigens
作者
关键词
-
出版物
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 24, Issue 48, Pages 5418-5432
出版商
Baishideng Publishing Group Inc.
发表日期
2018-12-27
DOI
10.3748/wjg.v24.i48.5418
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing
- (2018) M. B. Mogensen et al. BMC CANCER
- The Impact of Microsatellite stability status in colorectal cancer
- (2018) Ruby Gupta et al. CURRENT PROBLEMS IN CANCER
- Soluble PD-1-based vaccine targeting MUC1 VNTR and survivin improves anti-tumor effect
- (2018) Chenlu Liu et al. IMMUNOLOGY LETTERS
- Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma
- (2018) Jason Chesney et al. JOURNAL OF CLINICAL ONCOLOGY
- Multicenter, phase II clinical trial of peptide vaccination with oral chemotherapy following curative resection for stage�III colorectal cancer
- (2018) Junichiro Kawamura et al. Oncology Letters
- Complex pattern of immune evasion in MSI colorectal cancer
- (2018) Mine Ozcan et al. OncoImmunology
- Retained Introns Can Produce Tumor-Specific Neoepitopes in Melanoma
- (2018) Cancer Discovery
- Targeting nonsense-mediated mRNA decay in colorectal cancers with microsatellite instability
- (2018) A’dem Bokhari et al. Oncogenesis
- Revealing the Determinants of Widespread Alternative Splicing Perturbation in Cancer
- (2017) Yongsheng Li et al. Cell Reports
- T cell therapy targeting a public neoantigen in microsatellite instable colon cancer reduces in vivo tumor growth
- (2017) Else M. Inderberg et al. OncoImmunology
- Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma
- (2016) Igor Puzanov et al. JOURNAL OF CLINICAL ONCOLOGY
- MAGE-A is More Highly Expressed Than NY-ESO-1 in a Systematic Immunohistochemical Analysis of 3668 Cases
- (2016) Sid P. Kerkar et al. JOURNAL OF IMMUNOTHERAPY
- T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
- (2016) Eric Tran et al. NEW ENGLAND JOURNAL OF MEDICINE
- A cancer-favoring oncolytic vaccinia virus shows enhanced suppression of stem-cell like colon cancer
- (2016) So Young Yoo et al. Oncotarget
- Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma
- (2016) Marios Giannakis et al. Cell Reports
- Oncolytic herpes simplex virus kills stem-like tumor-initiating colon cancer cells
- (2016) Susanne G Warner et al. Molecular Therapy-Oncolytics
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
- (2015) Michael S. Rooney et al. CELL
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Identification of T-cell Receptors Targeting KRAS-Mutated Human Tumors
- (2015) Q. J. Wang et al. Cancer Immunology Research
- A Safety and Feasibility Study of an Allogeneic Colon Cancer Cell Vaccine Administered with a Granulocyte–Macrophage Colony Stimulating Factor–Producing Bystander Cell Line in Patients with Metastatic Colorectal Cancer
- (2014) Lei Zheng et al. ANNALS OF SURGICAL ONCOLOGY
- Therapeutic effect of a TM4SF5-specific peptide vaccine against colon cancer in a mouse model
- (2014) Sanghoon Kwon et al. BMB Reports
- Is the "3+3" Dose-Escalation Phase I Clinical Trial Design Suitable for Therapeutic Cancer Vaccine Development? A Recommendation for Alternative Design
- (2014) O. E. Rahma et al. CLINICAL CANCER RESEARCH
- Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival
- (2014) S. D. Brown et al. GENOME RESEARCH
- A phase I study of combination vaccine treatment of five therapeutic epitope-peptides for metastatic colorectal cancer; safety, immunological response, and clinical outcome
- (2014) Shoichi Hazama et al. Journal of Translational Medicine
- CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survival
- (2014) Viktor H Koelzer et al. Journal of Translational Medicine
- The immunological and clinical effects of mutated ras peptide vaccine in combination with IL-2, GM-CSF, or both in patients with solid tumors
- (2014) Osama E Rahma et al. Journal of Translational Medicine
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells
- (2014) Loek J. Eggermont et al. TRENDS IN BIOTECHNOLOGY
- The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints
- (2014) Nicolas J. Llosa et al. Cancer Discovery
- Phase II Study of Personalized Peptide Vaccination for Previously Treated Advanced Colorectal Cancer
- (2014) S. Kibe et al. Cancer Immunology Research
- Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
- (2013) G. P. Linette et al. BLOOD
- Peptide Vaccines and Peptidomimetics of EGFR (HER-1) Ligand Binding Domain Inhibit Cancer Cell Growth In Vitro and In Vivo
- (2013) K. C. Foy et al. JOURNAL OF IMMUNOLOGY
- Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
- (2013) Richard A. Morgan et al. JOURNAL OF IMMUNOTHERAPY
- Mechanisms of Action of Adjuvants
- (2013) Sunita Awate et al. Frontiers in Immunology
- MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility Study
- (2012) T. Kimura et al. Cancer Prevention Research
- First clinical trial of cancer vaccine therapy with artificially synthesized helper/ killer-hybrid epitope long peptide of MAGE-A4 cancer antigen
- (2012) Norihiko Takahashi et al. CANCER SCIENCE
- Recent Advances in Active Specific Cancer Vaccine Treatment for Colorectal Cancer
- (2012) Kiyotaka Okuno et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Trial watch
- (2012) Erika Vacchelli et al. OncoImmunology
- Cytokine adjuvants for vaccine therapy of neoplastic and infectious disease
- (2011) William K. Decker et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer
- (2011) Cecily P. Vaughn et al. GENES CHROMOSOMES & CANCER
- Nonsense Mediated Decay Resistant Mutations Are a Source of Expressed Mutant Proteins in Colon Cancer Cell Lines with Microsatellite Instability
- (2011) David S. Williams et al. PLoS One
- An MSI Tumor Specific Frameshift Mutation in a Coding Microsatellite of MSH3 Encodes for HLA-A0201-Restricted CD8+ Cytotoxic T Cell Epitopes
- (2011) Yvette Garbe et al. PLoS One
- Efficient induction of anti-tumor immunity by a TAT-CEA fusion protein vaccine with poly(I:C) in a murine colorectal tumor model
- (2011) Jung-Sun Park et al. VACCINE
- Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients
- (2010) Vanessa Deschoolmeester et al. BMC IMMUNOLOGY
- Cyclophosphamide Synergizes with Type I Interferons through Systemic Dendritic Cell Reactivation and Induction of Immunogenic Tumor Apoptosis
- (2010) G. Schiavoni et al. CANCER RESEARCH
- T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
- (2010) Maria R Parkhurst et al. MOLECULAR THERAPY
- Characteristics of severe adverse events after peptide vaccination for advanced cancer patients: Analysis of 500 cases
- (2010) Yamada ONCOLOGY REPORTS
- Identification of HLA-A*0201/-A*2402-restricted CTL epitope-peptides derived from a novel cancer/testis antigen, MCAK, and induction of a specific antitumor immune response
- (2010) Mori ONCOLOGY REPORTS
- Phase I clinical trial of a novel peptide vaccine in combination with UFT/LV for metastatic colorectal cancer
- (2010) KIYOTAKA OKUNO et al. Experimental and Therapeutic Medicine
- Immunological evaluation of personalized peptide vaccination in combination with UFT and UZEL for metastatic colorectal carcinoma patients
- (2009) Takashi Hattori et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immunogenic death of colon cancer cells treated with oxaliplatin
- (2009) A Tesniere et al. ONCOGENE
- Pilot study of mutant ras peptide-based vaccine as an adjuvant treatment in pancreatic and colorectal cancers
- (2008) Antoun Toubaji et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentation
- (2008) Martijn S. Bijker et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Prediction of the immunogenic potential of frameshift-mutated antigens in microsatellite instable cancer
- (2008) Frank M. Speetjens et al. INTERNATIONAL JOURNAL OF CANCER
- Alternative Splicing in Colon, Bladder, and Prostate Cancer Identified by Exon Array Analysis
- (2008) Kasper Thorsen et al. MOLECULAR & CELLULAR PROTEOMICS
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
- The tumor microenvironment and its role in promoting tumor growth
- (2008) T L Whiteside ONCOGENE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started